Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-18

Clinical Trial Update: A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and tolerability of multiple doses of HRS-7535 in overweight or obese adults; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Overweight or Obesity | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING